Frank Rimerman Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-6,101
Closed -$262K 621
2026
Q1
$262K Buy
6,101
+33
+0.5% +$1.42K 0.02% 525
2025
Q4
$266K Buy
6,068
+37
+0.6% +$1.53K 0.02% 538
2025
Q3
$249K Sell
6,031
-86
-1% -$3.46K 0.02% 528
2025
Q2
$270K Sell
6,117
-225
-4% -$8.99K 0.02% 480
2025
Q1
$234K Buy
6,342
+285
+5% +$10.2K 0.02% 464
2024
Q4
$202K Buy
+6,057
New +$196K 0.01% 506

Other funds holding EXEL

Frank Rimerman Advisors's EXEL Position: Q2 2026 in Review

Frank Rimerman Advisors sold out of Exelixis (EXEL) in Q2 2026, closing a stake of 6,101 shares — an estimated $262K sold.

Frank Rimerman Advisors first reported a position in EXEL in Q4 2024 and held it in 6 quarters. The position peaked at $270K in Q2 2025. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Frank Rimerman Advisors reported no remaining Exelixis position as of Q2 2026 after selling out during the quarter.
  • Frank Rimerman Advisors sold 6,101 Exelixis shares in Q2 2026, an estimated $262K.
  • Frank Rimerman Advisors first reported a position in Exelixis in Q4 2024 and held it in 6 quarters.
  • Frank Rimerman Advisors's Exelixis position peaked at $270K in Q2 2025.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Frank Rimerman Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.